Recon: China suspends sale of Sun dementia drug; Intellia cleared to resume gene therapy trial after FDA hold
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States